News
21
2023-03
BrosMed Announced CE MDR Approval of Tiche™ 0.035”High Pressure PTA Balloon Dilatation Catheter
March 21, 2023- BrosMed today announced that it receives European Medical Device Regulation (MDR) certification for Tiche™ 0.035” High Pressure PTA Balloon Dilatation Catheter which is designed for the treatment of severely calcified peripheral vascular disease and challenging AV cases. It is the first MDR certificate of BrosMed and also a successful conformity assessment which set a precedent for the future.
2023-03-21
29
2022-11
BrosMed Medical Announces Japanese Approval and Launch of Rokku Exchange Device In Japan Market
Guangdong, China [Nov. 24, 2022] – BrosMed Medical announced its exchange device has received the Japan PMDA approval.
2022-11-29
01
2022-03
BrosMed Enters 10th Anniversary Year
BrosMed Medical Co., Ltd.(“BrosMed”) is celebrating its 10 year anniversary today!
2022-03-01
19
2021-11
With the support from you and all our colleagues, BrosMed MEDICA 2021 has crowned with complete success and made a grand exposure from 15-18 November. Thank you for visiting our booth and Let’s looking forward to meet at next MEDICA 2022!
2021-11-19
01
2021-06
Brosmed receives CE mark approval for POT™ PTCA balloon catheter
Sittard, Netherlands [May 24, 2021] –Brosmed, a medical device company developing and commercializing innovative interventional treatment systems for patients with coronary and peripheral disease today announced she received CE Mark approval in the European Union for its POT™ PTCA balloon catheter, a dedicated balloon for the proximal and distal optimization technique(PDOT).
2021-06-01
26
2021-05
Brosmed receives CE mark approval for Pronavi™ Microcatheter
Sittard, Netherlands [May 26, 2021] –Brosmed, a medical device company developing and commercializing innovative interventional treatment systems for patients with coronary and peripheral disease today announced she received CE Mark approval in the European Union for its Pronavi™ Microcatheter .Device is indicated for use in both coronary and peripheral interventions.
2021-05-26
24
2021-05
Guangdong ,China [May 24 , 2021] – Brosmed Ltd. today announced that she has received a 510(k) clearance from the U.S. Food & Drug Administration for its Artimes™ Pro PTCA balloon catheter. Artimes™ Pro is a novel PTCA semi-compliant rapid-exchange balloon dilatation catheter manufactured with specific features to facilitate complex coronary interventions.
2021-05-24
